Overweight

Overweight is the indication for 8 drugs in DrugBank. It is covered by 12 curated, structured indications.

Also known as: BMI >27 kg/m2 · Over Weight · Over-weight
Classified under: Adverse Drug Reactions
Behavior And Behavior Mechanism
Cardiovascular Diseases
Clinical Procedures, Devices, and Diagnostic Activities
Digestive System Diseases
Disease and Non-Disease Concepts, Unclassified
Gastrointestinal signs and symptoms NEC
Nutritional and Metabolic Diseases
Public Health
Signs, Symptoms, and General Pathologies
Indicated drugs: Liraglutide
Naltrexone
Orforglipron
Orlistat
Phentermine
Semaglutide
Tirzepatide
Topiramate

Resolves to

Vocabularies

MeSHM0473031ICD-10E66.3SNOMED CT238131007MedDRA10033307UMLSC0497406

What you can answer from here — as of November 01, 2026

8Indicated drugsWith each drug's targets and mechanism

Listed above

12Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

993Clinical trialsPhase, status and sponsor resolved per trial

2Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Overweight share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.